الفهرس 
HemoglobinOnly 14 pages are availabe for public view
 |  | from | 155 |  |  |
| | | from | 155 | | |
Abstract
This study aimed to evaluate the impact of hemoglobin level as predictor of MACE and mortality during in-hospital stay and after 30-day follow up at cardiology department, Tanta University. The study was conducted on 100 patients that were divided into 2 groups. group I consisted of 50 patients that had anemia according to WHO definition of anemia & group II consisted of 50 patients that were not anemic. Both groups were subdivided into A subgroups that underwent revascularization by pPCI and B subgroups that underwent revascularization by pharmacoinvasive strategy. The anemic patients tended to have more comorbidities ( hypertensive , diabetic , IHD and CKD ) . Although there was no significant difference in LVEF , infarct site and final TIMI flow , the anemic groups showed statistically significant more total MACE than non anemic groups whether revascularized by pPCI or pharmacoinvasive strategy . Although the anemic groups had more mortality , CHF , stroke and reinfarction in hospital and after 1 month follow up the difference for each complication was not significant most probably due to relatively small sample size As expected anemic patients tended to have higher bleeding complications especially those undergoing pharmacoinvasive strategy. The anemic patients also were less likely to be discharged on RAAS and beta blockers .